athenahealth Inc. (NASDAQ:ATHN) had its price objective upped by Jefferies Group from $105.00 to $110.00 in a research note published on Friday morning. Jefferies Group currently has an underperform rating on the stock.

Other analysts have also issued reports about the stock. Deutsche Bank AG lowered shares of athenahealth from a buy rating to a hold rating and decreased their target price for the company from $165.00 to $147.00 in a research report on Friday, July 22nd. Zacks Investment Research upgraded shares of athenahealth from a sell rating to a hold rating in a research report on Thursday, August 4th. Morgan Stanley reduced their price target on shares of athenahealth from $186.00 to $153.00 and set an overweight rating on the stock in a research report on Monday, July 25th. Canaccord Genuity restated a hold rating and issued a $142.00 price target on shares of athenahealth in a research report on Wednesday, June 29th. Finally, FBR & Co reduced their price target on shares of athenahealth from $145.00 to $140.00 and set a market perform rating on the stock in a research report on Friday, July 22nd. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and nine have issued a buy rating to the company. The stock has an average rating of Hold and a consensus price target of $149.95.

athenahealth (NASDAQ:ATHN) traded up 1.12% on Friday, hitting $124.80. 259,652 shares of the company were exchanged. The firm has a market cap of $4.91 billion, a price-to-earnings ratio of 458.82 and a beta of 1.28. The stock has a 50 day moving average price of $123.67 and a 200 day moving average price of $129.65. athenahealth has a one year low of $114.59 and a one year high of $170.42.

athenahealth (NASDAQ:ATHN) last issued its earnings results on Thursday, July 21st. The company reported $0.34 earnings per share for the quarter, missing the consensus estimate of $0.42 by $0.08. athenahealth had a net margin of 1.06% and a return on equity of 5.16%. The business had revenue of $261.90 million for the quarter, compared to analyst estimates of $274.07 million. On average, equities research analysts forecast that athenahealth will post $1.77 EPS for the current fiscal year.

In other athenahealth news, SVP Bradford Kyle Armbrester sold 2,545 shares of the firm’s stock in a transaction dated Monday, October 10th. The shares were sold at an average price of $130.00, for a total value of $330,850.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Brandon H. Hull sold 2,400 shares of the firm’s stock in a transaction dated Monday, October 10th. The shares were sold at an average price of $130.00, for a total transaction of $312,000.00. Following the completion of the transaction, the director now directly owns 3,987 shares in the company, valued at $518,310. The disclosure for this sale can be found here. Corporate insiders own 3.04% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the stock. Janus Capital Management LLC raised its position in athenahealth by 22.3% in the second quarter. Janus Capital Management LLC now owns 4,104,647 shares of the company’s stock valued at $566,471,000 after buying an additional 749,497 shares in the last quarter. Wellington Management Group LLP raised its position in athenahealth by 10.3% in the first quarter. Wellington Management Group LLP now owns 3,645,875 shares of the company’s stock valued at $505,975,000 after buying an additional 339,472 shares in the last quarter. Emerald Acquisition Ltd. purchased a new position in athenahealth during the second quarter valued at approximately $28,575,000. State Treasurer State of Michigan raised its position in athenahealth by 11,337.5% in the second quarter. State Treasurer State of Michigan now owns 183,000 shares of the company’s stock valued at $25,256,000 after buying an additional 181,400 shares in the last quarter. Finally, Ruane Cunniff & Goldfarb Inc. raised its position in athenahealth by 50.0% in the second quarter. Ruane Cunniff & Goldfarb Inc. now owns 300,095 shares of the company’s stock valued at $41,416,000 after buying an additional 100,095 shares in the last quarter.

About athenahealth

athenahealth, Inc is a provider of cloud-based services and mobile applications for medical groups and health systems. The Company delivers cloud-based services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, care coordination, order transmission, population health management, and clinical decision support.

5 Day Chart for NASDAQ:ATHN

Receive News & Stock Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related stocks with our FREE daily email newsletter.